NCT04814329View on ClinicalTrials.gov

Glioblastoma Response Prediction to Apatinib

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Glioblastoma
Interventions
OTHER

genetic characteristic

the underlying genetic characteristics that prodicting response

Trial Locations (1)

Unknown

Capital Medical University Sanbo Brain Hospital, Beijing

All Listed Sponsors
lead

Beijing Sanbo Brain Hospital

OTHER